WINDTREE THERAPEUTICS INC /DE/ cotiza a 0.00 USD y tiene una capitalización bursátil de $33709. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of earl…
| Periodo | 2024-11 | 2024-08 | 2024-05 | 2024-04 |
|---|---|---|---|---|
| Real | $-211.50 | $-1045.50 | $1099.00 | $-666.00 |
| Estimado | $-113.50 | $-405.50 | $-495.00 | $-846.00 |
| Sorpresa | -86.3% | -157.8% | +322.0% | +21.3% |
| Métrica | WINT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -17.9% | -40.4% | +22.5% |
| ROA | -6.4% | -32.0% | +25.6% |
| Current Ratio | 0.45 | 2.84 | -2.39 |
| Debt / Equity | — | 0.28 | — |